Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors

The development of lethal, castration resistant prostate cancer is associated with adaptive changes to the androgen receptor (AR), including the emergence of mutant receptors and truncated, constitutively active AR variants. AR relies on the molecular chaperone HSP90 for its function in both normal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gillis, Joanna L., Selth, Luke A., Centenera, Margaret M., Townley, Scott L., Sun, Shihua, Plymate, Stephen R., Tilley, Wayne D., Butler, Lisa M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2013
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742830/
https://ncbi.nlm.nih.gov/pubmed/23674566
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars